Molecular imaging using magnetic resonance: new tools for the development of tumour therapy
Author:
- 1 December 2003
- journal article
- review article
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 76 (suppl_2) , S111-S117
Abstract
Molecular imaging – the exploitation of specific molecules as the source of image contrast – promises new insights into disease processes in the laboratory and since the imaging modalities employed are applicable clinically, can be used to translate this knowledge into new diagnostics and treatments in the clinic. This brief review focuses on the use of MR-based molecular imaging techniques for developing tumour therapy. As examples, methods for detecting drug-induced tumour cell apoptosis; the response of tumours and their susceptibilities to an antivascular drug; early signs of tumour immune rejection and methods for detecting immune cell infiltration of tumours are described.Keywords
This publication has 56 references indexed in Scilit:
- Molecular imaging in living subjects: seeing fundamental biological processes in a new lightGenes & Development, 2003
- MRI of insulitis in autoimmune diabetesMagnetic Resonance in Medicine, 2002
- EditorialNMR in Biomedicine, 2002
- Scaling down imaging: molecular mapping of cancer in miceNature Reviews Cancer, 2002
- Magnetic resonance contrast enhancement of neovasculature with ?v?3-targeted nanoparticlesMagnetic Resonance in Medicine, 2000
- Inhibition of Phosphatidylcholine Biosynthesis following Induction of Apoptosis in HL-60 CellsJournal of Biological Chemistry, 1999
- THE GREEN FLUORESCENT PROTEINAnnual Review of Biochemistry, 1998
- The development of in vivo imaging systems to study gene expressionTrends in Biotechnology, 1998
- Assessing tumor angiogenesis using macromolecular MR imaging contrast mediaJournal of Magnetic Resonance Imaging, 1997
- Apoptosis in murine tumors treated with chemotherapy agentsAnti-Cancer Drugs, 1995